Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Atopic Dermatitis · Alopecia Areata

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Giselle Singer) · giselle.singer@mssm.edu · 212-241-3288
Contact: Principal Investigator (Emma Guttman)

Study leads

Emma Guttman, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Dusan Bogunovic, PhD
Principal Investigator
Columbia University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Atopic Dermatitis

Abroad (travel likely)Recruiting

New York, United States

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Alpharetta, United States · Troy, United States

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Atopic Dermatitis (AD)

Abroad (travel likely)RecruitingPHASE2

Beijing, China